Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Lawmakers grill U.S. FDA on response to Abbott baby formula safety

Stock Markets May 25, 2022 04:46PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
2/2 © Reuters. FILE PHOTO: Empty shelves show a shortage of baby formula at a CVS store in San Antonio, Texas, U.S. May 10, 2022. REUTERS/Kaylee Greenlee Beal/File Photo 2/2

By Ahmed Aboulenein and Manas Mishra

WASHINGTON (Reuters) -Lawmakers grilled U.S. Food and Drug Administration officials on Wednesday over what they saw as a lack of urgency in the agency's response to complaints about possible baby formula contamination at a now shuttered Abbott Laboratories (NYSE:ABT) plant that led to severe nationwide shortages.

FDA leaders appeared before a congressional panel to answer questions about the crisis after Abbott in February recalled some products and closed its manufacturing plant in Sturgis, Michigan.

"There are also questions surrounding the timeline of FDA's investigation and response," said Representative Diana DeGette, chairwoman of the U.S. House of Representatives Commerce and Energy Subcommittee on Oversight and Investigations.

The Democrat cited "a four-month lapse before returning to inspect the Sturgis facility," and a delay in contacting a former Abbott employee whistleblower.

Senior leaders like then-acting Commissioner Janet Woodcock and Deputy Commissioner for Food Policy and Response Frank Yiannas only saw the complaint in February because of pandemic-related mail routing issues, FDA officials said.

"FDA's timeliness of interviewing the whistleblower and getting into the facility for a for-cause inspection were too slow and some decisions could have been more optimal," acknowledged FDA Commissioner Robert Califf.

"To my knowledge, there's no malfeasance there. These are people who are working very hard, but we had systems that were failing and decisions that could have been better."

The FDA inspected the plant following reports of bacterial infections in babies potentially linked to Abbott's formula, and the whistleblower complaint in late October.

A COVID outbreak at the plant delayed the inspection until Jan. 31. A second baby's death potentially linked to the plant was reported just after the factory was shuttered in February.

"Frankly, the inspection results were shocking," Califf said, noting that inspectors found cracks in vital equipment, a lack of adequate hand washing, evidence of previous bacterial contamination, and water leaks in areas were formula is produced, a risk factor for bacteria.

The plant is one of three run by Abbott, which has the largest U.S. market share for infant formula, and the company did not have a contingency plan to produce its specialty formulas that serve as the only source of nutrition for thousands of babies with metabolic disorders, the FDA said.

Califf said the best option was to enter into a consent decree agreement with Abbott, "where we literally have oversight of every single step" of remediation of problems at the facility to get it back on line as soon as possible.

Abbott plans to reopen the plant on June 4.

Abbott controlled 40% of the market before the plant closed, Christopher Calamari, president of Abbott U.S. nutrition, told lawmakers, and the plant accounts for 40% of Abbott's product.

Reckitt Benckriser had a 34% market share that grew to 56% since the closure, vice president for nutrition Robert Cleveland told lawmakers. Nestle saw its 8% share grow to 9%, Gerber vice president Scott Fitz said.

Lawmakers grill U.S. FDA on response to Abbott baby formula safety
 

Related Articles

SAS and its pilots extend wage talks until Monday
SAS and its pilots extend wage talks until Monday By Reuters - Jul 02, 2022 3

STOCKHOLM (Reuters) -Scandinavian airline SAS and its pilots have agreed to extend their wage talks until Monday in the hope of averting a strike, a company executive told...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email